Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User Fee Program Would Allow CDRH To Increase Personnel, Feigal Says

This article was originally published in The Gray Sheet

Executive Summary

Funding from a device user fee program would enable CDRH to hire as many as 100 new FTEs, according to Center Director David Feigal

You may also be interested in...



Device User Fee Program Future May Hinge On Lobbying Approps Staff

Improved relations with Capitol Hill staffers responsible for FDA appropriations will be key to industry's efforts to sustain the medical device user fee program and ensure that premarket review performance goals are met

Device User Fee Program Future May Hinge On Lobbying Approps Staff

Improved relations with Capitol Hill staffers responsible for FDA appropriations will be key to industry's efforts to sustain the medical device user fee program and ensure that premarket review performance goals are met

IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel